News

Daxor Corporation Showcases BVA-100™ at MedAxiom CV Transforum

Daxor Corporation Showcases BVA-100™ at MedAxiom CV Transforum

Innovation in Cardiovascular Care at MedAxiom's CV Transforum

Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence

Oak Ridge, TN – Daxor Corporation (NASDAQ: DXR), a leader in blood volume measurement technology, proudly announces its participation at the MedAxiom Cardiovascular (CV) Transforum Fall’24 Conference. This prestigious event is set to occur at the Gaylord Rockies Resort & Convention Center, where cardiovascular experts and industry leaders will gather to share insights and innovations that enhance cardiovascular care.

Daxor’s presence at this conference marks a significant opportunity to connect with prominent figures in cardiovascular medicine. "We are excited to engage with fellow innovators and showcase how our blood volume analysis technology addresses critical challenges faced in healthcare, such as reducing hospital readmissions and improving patient survival rates. MedAxiom has a proven track record of fostering collaborations that lead to impactful solutions, making it the perfect venue for us to highlight our technology," stated Michael Feldschuh, CEO and President of Daxor Corporation.

Impact of BVA Guided Care on Patient Outcomes

The BVA guided care approach has been validated through peer-reviewed studies, displaying remarkable improvements in patient outcomes. Significant findings include an 82% reduction in 30-day mortality, a 56% decrease in 30-day hospital readmissions, and an impressive 57% reduction in hospital length of stay when BVA testing is conducted upon patient admission (P<0.001). This technology equips healthcare professionals with highly accurate data—boasting 98% accuracy—to optimize treatment plans tailored to individual patient needs, thereby enhancing both outcomes and cost-effectiveness.

Understanding Daxor Corporation's Mission

Daxor Corporation (NASDAQ: DXR) is dedicated to revolutionizing patient care through its innovative blood volume measurement technology. The company has introduced the BVA-100, the only FDA-cleared diagnostic blood test that delivers precise and objective quantification of blood volume status in comparison to patient-specific norms. This technology has successfully conducted over 65,000 tests across leading hospitals, demonstrating a significant positive impact on performance metrics across various medical and surgical settings.

With strong evidence indicating improvements in mortality and readmissions for heart failure and critical care, Daxor is actively involved in several clinical trials focusing on heart failure treatments, backed by support from the NIH. In addition, the company is collaborating with the U.S. Department of Defense to enhance combat casualty care through advanced analyzers, underlining its commitment to optimal fluid management in healthcare.

Join Daxor on Their Journey

Daxor's vision extends to ensuring optimal blood volume for everyone, which it achieves through innovative testing and analysis. For healthcare professionals and institutions looking for advanced solutions in patient management, Daxor maintains a dedicated platform where individuals can stay updated about new technologies and advancements in this medical field.

For more detailed information about Daxor Corporation, its technologies, and opportunities to engage with the company, interested parties are encouraged to visit their official webpage. With continuous advancements and support from both the healthcare community and federal agencies, Daxor is at the forefront of improving care quality through science and technology.

Frequently Asked Questions

What is Daxor Corporation known for?

Daxor Corporation is known for its pioneering blood volume measurement technology, specifically the BVA-100 diagnostic tool.

When is the MedAxiom CV Transforum event taking place?

The MedAxiom CV Transforum is occurring from October 17-19, 2024.

How does BVA guided care impact patient outcomes?

BVA guided care has demonstrated improvements such as an 82% reduction in 30-day mortality and a 56% reduction in hospital readmissions.

Is Daxor involved in any clinical trials?

Yes, Daxor is conducting several clinical trials focusing on heart failure treatments, supported by the NIH.

How can I stay updated with Daxor's innovations?

Individuals can visit Daxor’s official website to sign up for updates on their latest technologies and advancements in healthcare.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 318

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 331

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 393

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 275

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 240

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 239

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 298

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 110

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 163

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading

Top 5 Most Recently Viewed Articles

Vestaron Secures Over $20 Million to Boost Bioinsecticide Launch

Updated Category News Views 331

Vestaron Secures Major Funding to Propel Bioinsecticide Innovations In a significant step towards revolutionizing crop protection, Vestaron has successfully closed a funding round exceeding $20 million. This investment not only underscores the confidence investors have in Vestaron's groundbreaking peptide technology but also aims to expedite its market entry for...

Continue Reading
Lunai's Strategic Parkinson’s Partnership: What’s Ahead?

Updated Category News Views 55

Dialing Into the Lunai-BrainStorm Alliance When you hear about a biotech outfit like Lunai Bioworks shaking hands with BrainStorm Therapeutics, it’s time to sit up and tune into what could be major tremors in the medical arena. They've penned a Master Collaboration Agreement aiming to slam Parkinson's with a one-two punch of AI stratification and human brain...

Continue Reading
TotalEnergies Partners with OQAE for Major Renewable Energy Project

Updated Category News Views 202

TotalEnergies Collaborates with OQAE on Renewable Projects In an exciting development for renewable energy, TotalEnergies (NYSE:TTE) has joined forces with OQ Alternative Energy (OQAE) to spearhead the creation of 300 MW of renewable energy projects. This partnership aims to enhance energy security and contribute to a sustainable future through innovative solar and wind...

Continue Reading
What to Know Before Buying a Timeshare Resale

Updated Category Real Estate Views 324

A low resale price can make a timeshare look surprisingly attractive. Compared with buying directly from a developer, the difference can be substantial. But the purchase price is only one part of the decision. A timeshare resale comes with ongoing fees, booking rules, transfer conditions, and other obligations that can matter far more than the amount paid upfront. Before...

Continue Reading
Breaking Ground in Semiconductor Equipment Innovations

Updated Category News Views 277

E&R Engineering Corp.: Pioneering Advanced Packaging Solutions E&R Engineering Corp. stands at the forefront of the semiconductor industry, leveraging over 30 years of experience to supply cutting-edge packaging tools globally. As a leading provider based in Taiwan, E&R has established itself as a trusted partner by delivering more than 500 advanced semiconductor...

Continue Reading